Pivekimab Sunirine

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

7 Countries

Phase I/II

Phase I (Other)

Phase I (FiH)

Phase I/II: 1 Phase I (Other): 1 Phase I (FiH): 1

Sponsors using this IMP

AbbVie Deutschland GmbH & Co. KG 3

All trials

3 total

A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute M… Pending

2024-520125-36-00 Phase I (Other) 6 countries AbbVie Deutschland GmbH & Co. KG
A study of IMGN632 alone or in combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia Ended

2024-514197-50-00 Phase I/II 4 countries AbbVie Deutschland GmbH & Co. KG
A study to test IMGN632 in adults with CD123-positive Acute Myeloid Leukemia and other CD123 positive Hematologic cancers. Ended

2024-514195-40-00 Phase I (FiH) 2 countries AbbVie Deutschland GmbH & Co. KG

Showing 1–3 of 3 trials

← All drugs A–Z